 SOUTH SAN FRANCISCO, Calif., May 26, 2021 GLOBE NEWSWIRE -- Alector, Inc. Nasdaq: ALEC, a clinical-stage biotechnology company pioneering immuno-neurology, today announced that it will host a virtual key opinion leader event focused on frontotemporal dementia due to a progranulin gene mutation FTD-GRN on Friday, June 11, 2021 at 10:30 a.m. ET. 